Cargando…

Comparison of serum interleukin-10 level of fungal exposure among patients with pulmonary sarcoidosis and healthy people

Introduction: Sarcoidosis is a chronic systemic inflammatory disease with unknown etiology. Fungal exposure has been assumed as one of many possible causes of the disease. The prevalence of sarcoidosis is likely to be higher in the Northern Iran compared with other regions. Environmental studies hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Alavi Foumani, Seyed Ali, Geranmayeh, Siamak, Tangestani Nejad, Azita, Pour Kazemi, Aydin, Kazem Nejad Leili, Ehsan, Jafari, Alireza, Amooei Khanabbasi, Mehrzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170126/
https://www.ncbi.nlm.nih.gov/pubmed/32476916
http://dx.doi.org/10.36141/svdld.v35i4.6757
_version_ 1783523841011613696
author Alavi Foumani, Seyed Ali
Geranmayeh, Siamak
Tangestani Nejad, Azita
Pour Kazemi, Aydin
Kazem Nejad Leili, Ehsan
Jafari, Alireza
Amooei Khanabbasi, Mehrzad
author_facet Alavi Foumani, Seyed Ali
Geranmayeh, Siamak
Tangestani Nejad, Azita
Pour Kazemi, Aydin
Kazem Nejad Leili, Ehsan
Jafari, Alireza
Amooei Khanabbasi, Mehrzad
author_sort Alavi Foumani, Seyed Ali
collection PubMed
description Introduction: Sarcoidosis is a chronic systemic inflammatory disease with unknown etiology. Fungal exposure has been assumed as one of many possible causes of the disease. The prevalence of sarcoidosis is likely to be higher in the Northern Iran compared with other regions. Environmental studies have shown higher levels of fungal spores in the air of this area. Some studies have shown that fungal exposure in patients with sarcoidosis is associated with decreased levels of interleukin-10 (IL-10) serum levels. The aim of present study was comparison of the serum levels of IL-10 in patients with pulmonary sarcoidosis and healthy people. Objectives and Methods: In this current analytical, cross-sectional study, 40 patients with pulmonary sarcoidosis compared with 34 healthy individuals as a control group, who had been visited in a pulmonary referral clinic in Rasht (Guilan-Iran). Demographic data were collected by a questionnaire. Serum IL-10 levels were measured by ELISA kit. The data were analyzed by using the SPSS software (version 19). Results: The mean concentration of IL-10 serum levels were reported 10.96±9.48 pg/ml(-1) and 3.77±1.47 pg/ml(-1) among the patients with pulmonary sarcoidosis and healthy individuals, respectively. The significance difference was demonstrated between patients with pulmonary sarcoidosis and control group (p<0.0001). The IL-10 showed a significant difference between the patients older than 40 and those younger than 40. In statistical analysis, 4.75 pg.ml(-1) was considered the cutoff point to separate patients and control group. Conclusion: The results showed that IL-10 was greater among patients who diagnosed as pulmonary sarcoidosis. There was a contrary opinion of the expectations for the role of fungal exposure as a possible cause of greater prevalence of sarcoidosis in Northern Iran. Age and stage of disease showed a significant relationship with the IL-10 serum level and requires further investigation. IL-10 might be a possible predictor of sarcoidosis along with other factors. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35: 294-298)
format Online
Article
Text
id pubmed-7170126
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-71701262020-05-29 Comparison of serum interleukin-10 level of fungal exposure among patients with pulmonary sarcoidosis and healthy people Alavi Foumani, Seyed Ali Geranmayeh, Siamak Tangestani Nejad, Azita Pour Kazemi, Aydin Kazem Nejad Leili, Ehsan Jafari, Alireza Amooei Khanabbasi, Mehrzad Sarcoidosis Vasc Diffuse Lung Dis Original Article: Clinical Research Introduction: Sarcoidosis is a chronic systemic inflammatory disease with unknown etiology. Fungal exposure has been assumed as one of many possible causes of the disease. The prevalence of sarcoidosis is likely to be higher in the Northern Iran compared with other regions. Environmental studies have shown higher levels of fungal spores in the air of this area. Some studies have shown that fungal exposure in patients with sarcoidosis is associated with decreased levels of interleukin-10 (IL-10) serum levels. The aim of present study was comparison of the serum levels of IL-10 in patients with pulmonary sarcoidosis and healthy people. Objectives and Methods: In this current analytical, cross-sectional study, 40 patients with pulmonary sarcoidosis compared with 34 healthy individuals as a control group, who had been visited in a pulmonary referral clinic in Rasht (Guilan-Iran). Demographic data were collected by a questionnaire. Serum IL-10 levels were measured by ELISA kit. The data were analyzed by using the SPSS software (version 19). Results: The mean concentration of IL-10 serum levels were reported 10.96±9.48 pg/ml(-1) and 3.77±1.47 pg/ml(-1) among the patients with pulmonary sarcoidosis and healthy individuals, respectively. The significance difference was demonstrated between patients with pulmonary sarcoidosis and control group (p<0.0001). The IL-10 showed a significant difference between the patients older than 40 and those younger than 40. In statistical analysis, 4.75 pg.ml(-1) was considered the cutoff point to separate patients and control group. Conclusion: The results showed that IL-10 was greater among patients who diagnosed as pulmonary sarcoidosis. There was a contrary opinion of the expectations for the role of fungal exposure as a possible cause of greater prevalence of sarcoidosis in Northern Iran. Age and stage of disease showed a significant relationship with the IL-10 serum level and requires further investigation. IL-10 might be a possible predictor of sarcoidosis along with other factors. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35: 294-298) Mattioli 1885 2018 2018-12-05 /pmc/articles/PMC7170126/ /pubmed/32476916 http://dx.doi.org/10.36141/svdld.v35i4.6757 Text en Copyright: © 2018 http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Article: Clinical Research
Alavi Foumani, Seyed Ali
Geranmayeh, Siamak
Tangestani Nejad, Azita
Pour Kazemi, Aydin
Kazem Nejad Leili, Ehsan
Jafari, Alireza
Amooei Khanabbasi, Mehrzad
Comparison of serum interleukin-10 level of fungal exposure among patients with pulmonary sarcoidosis and healthy people
title Comparison of serum interleukin-10 level of fungal exposure among patients with pulmonary sarcoidosis and healthy people
title_full Comparison of serum interleukin-10 level of fungal exposure among patients with pulmonary sarcoidosis and healthy people
title_fullStr Comparison of serum interleukin-10 level of fungal exposure among patients with pulmonary sarcoidosis and healthy people
title_full_unstemmed Comparison of serum interleukin-10 level of fungal exposure among patients with pulmonary sarcoidosis and healthy people
title_short Comparison of serum interleukin-10 level of fungal exposure among patients with pulmonary sarcoidosis and healthy people
title_sort comparison of serum interleukin-10 level of fungal exposure among patients with pulmonary sarcoidosis and healthy people
topic Original Article: Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170126/
https://www.ncbi.nlm.nih.gov/pubmed/32476916
http://dx.doi.org/10.36141/svdld.v35i4.6757
work_keys_str_mv AT alavifoumaniseyedali comparisonofseruminterleukin10leveloffungalexposureamongpatientswithpulmonarysarcoidosisandhealthypeople
AT geranmayehsiamak comparisonofseruminterleukin10leveloffungalexposureamongpatientswithpulmonarysarcoidosisandhealthypeople
AT tangestaninejadazita comparisonofseruminterleukin10leveloffungalexposureamongpatientswithpulmonarysarcoidosisandhealthypeople
AT pourkazemiaydin comparisonofseruminterleukin10leveloffungalexposureamongpatientswithpulmonarysarcoidosisandhealthypeople
AT kazemnejadleiliehsan comparisonofseruminterleukin10leveloffungalexposureamongpatientswithpulmonarysarcoidosisandhealthypeople
AT jafarialireza comparisonofseruminterleukin10leveloffungalexposureamongpatientswithpulmonarysarcoidosisandhealthypeople
AT amooeikhanabbasimehrzad comparisonofseruminterleukin10leveloffungalexposureamongpatientswithpulmonarysarcoidosisandhealthypeople